Emergence of 'Living Intelligence' 2026-2031: violent transformative convergence between biological science, silicon-based sensor networks, and algorithmic orchestration — biological cells programmed with same precision as silicon computers. Living cel...
Predictor: Amy Webb
Prediction text
Emergence of 'Living Intelligence' 2026-2031: violent transformative convergence between biological science, silicon-based sensor networks, and algorithmic orchestration — biological cells programmed with same precision as silicon computers. Living cells programmed as environmental sensors, biological data processors, or autonomous chemical factories; fundamentally rewrites global supply chains for industrial chemicals, agricultural proteins, pharmaceutical compounds. | First >$1B revenue cell-programmed industrial product
Key catalyst: First >$1B revenue cell-programmed industrial product
Watch events: First commercial cell-programmed industrial chemical at scale
Resolution evidence
Ginkgo Bioworks, Synlogic, Zymergen-legacy foundries operational; AI-designed cell-programs scaling via BioNeMo + Recursion + Xaira.
Predictor: Amy Webb
Evidence about this node from Amy Webb is multiplied by κ in /api/intake. Lower κ = less weight; floors at 0.10 (effectively silenced) and caps at 1.00 (full weight).
Reference class
This node isn't linked to a reference class. The Bayesian update applies without outside-view blending.
Probability over time
Milestone chain
- 2027-01-15pendingQ1 window check-in (25%)
- 2026-06-01 → 2028-06-30pendingCultivated/cell-cultured meat reaches retail price parity in pilot SKUHow: Believer Meats, Mission Barns, Upside, or peer reports cultivated product priced within 20% of conventional equivalent in US/Singapore retailSource: deep_research_enrichedconf 40%
- 2026-06-01 → 2028-12-31pendingDARPA / BARDA / NIH multi-year synbio biomanufacturing program >$1B announcedHow: US federal agency announces program valued at >=$1B over 5 years for cell-programmed industrial materials, pharmaceuticals, or environmental sensorsSource: deep_research_enrichedconf 55%
- 2026-09-01 → 2028-12-31pendingAI-designed enzyme commercially licensed to Top-20 pharma or specialty chemical co.How: Public press release confirms a generative-AI-designed protein/enzyme licensed for commercial production by a Top-20 pharma or specialty-chemicals firmSource: deep_research_enrichedconf 70%
- 2026-12-01 → 2028-12-31pendingFirst cell-programmed industrial product passes $100M annual revenueHow: Public 10-K/10-Q from a synbio firm (Ginkgo, Amyris successor, Zymergen-spinout, Cultivarium, etc.) reports a single cell-programmed product at >=$100M trailing-12-month revenueSource: deep_research_enrichedconf 55%
- 2028-01-30pendingQ2 window check-in (50%)
- 2027-06-01 → 2029-12-31pendingCell-programmed environmental biosensor deployed at city-scaleHow: At least one US/EU/Singapore municipality publicly deploys engineered-cell environmental sensors at city or watershed scaleSource: deep_research_enrichedconf 35%
- 2029-02-12pendingQ3 window check-in (75%)
No downstream cascades — this prediction is a leaf in the dependency graph.
What if this resolves?
Click a button to clamp this prediction and run a Gibbs sample. Returns the predictions whose marginals shift most. ~30s per run; ideal for stress-testing "if X resolves, what else moves?"
Evidence chain
Network propagation neighbors
Top incoming (parents)
Edges that influence THIS node's belief
Top outgoing (children)
Predictions THIS node influences
No outgoing edges.
Ticker exposure
Adverse (4)
Prerequisites (4)
| Type | Pred | Title | Domain | Lag |
|---|---|---|---|---|
| correlate | S_HUMANOID_CONSUMER_2030 | Humanoid R3: 1M+ consumer by Nov 2030 | humanoid_deployment | — |
| killer | TK02 | AI Compute Supply Shock (TSMC/Taiwan Disruption) | — | — |
| killer | TK11 | Autonomous Regulatory Block (Level 4 Halt) | — | — |
| killer | TK06 | China-Taiwan Military Conflict | — | — |
Dependents (0)
| Type | Pred | Title | Domain | Lag |
|---|---|---|---|---|
| No dependents | ||||
Validations (1)
| Observed at | Status | By | Notes |
|---|---|---|---|
| 2026-04-29 | partial | thesis_timeline_v1.0_import | Ginkgo Bioworks, Synlogic, Zymergen-legacy foundries operational; AI-designed cell-programs scaling via BioNeMo + Recursion + Xaira. |
Linked documents (5)
| Sim | Source | Title | Market prob | Polarity | Reviewed | Published |
|---|---|---|---|---|---|---|
| 0.708 | manifold | Biotech creates a technology rivaling AI | 22% | mentions | pending | 2026-04-25 |
| 0.695 | arxiv | Embodied Neurocomputation: A Framework for Interfacing Biological Neural Cultures with Scaled Task-Driven Validation | — | mentions | pending | 2026-05-13 |
| 0.600 | arxiv | ORBIT: Learning Gene Program Co-Activation Structure for Cell-Type-Stratified Pathway Rewiring Analysis in Single-Cell Transcriptomics | — | mentions | pending | 2026-05-04 |
| 0.578 | arxiv | Machine Learning-Driven Multimodal Spectroscopic Liquid Biopsy for Early Multicancer Detection | — | mentions | pending | 2026-05-13 |
| 0.535 | edgar_8k | PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) (CIK 0001299130) | — | mentions | pending | 2026-06-04 |
Raw metadata
{
"nia": false,
"mode": "FORECAST",
"role": "Cited-Other",
"context": "Second Webb entry. Specific Living Intelligence coinage + biology-as-IT framing. Couples with IND_012 (Huang BioNeMo Evo 2), IND_020 (MS De Novo moment), CMQ_006 (Amodei cancer cure), IND_008 (biological freedom).",
"to_year": 2031,
"conv_cues": "coined framework; specific integration domains",
"direction": "HAPPEN",
"from_year": 2026,
"timeframe": "2026-2031",
"conv_level": "HIGH",
"milestones": [
{
"kind": "quartile_checkpoint",
"label": "Q1 window check-in (25%)",
"status": "pending",
"weight": 0.05,
"ordinal": -8,
"source_id": null,
"expected_date": "2027-01-15",
"observed_date": null
},
{
"kind": "llm_pre_event",
"label": "Cultivated/cell-cultured meat reaches retail price parity in pilot SKU",
"source": "deep_research_enriched",
"status": "pending",
"weight": 0.4,
"ordinal": -7,
"source_id": null,
"confidence": 0.4,
"source_url": "https://www.greenqueen.com.hk/mission-barns-lab-grown-pork-fat-fda-approved-cultivated-meat-sprouts-fiorella/",
"expected_date": "2027-06-16",
"research_origin": "deep_research",
"expected_date_range": {
"to": "2028-06-30",
"from": "2026-06-01"
},
"measurement_criterion": "Believer Meats, Mission Barns, Upside, or peer reports cultivated product priced within 20% of conventional equivalent in US/Singapore retail"
},
{
"kind": "llm_pre_event",
"label": "DARPA / BARDA / NIH multi-year synbio biomanufacturing program >$1B announced",
"source": "deep_research_enriched",
"status": "pending",
"weight": 0.4,
"ordinal": -6,
"source_id": null,
"confidence": 0.55,
"expected_date": "2027-09-16",
"research_origin": "deep_research",
"expected_date_range": {
"to": "2028-12-31",
"from": "2026-06-01"
},
"measurement_criterion": "US federal agency announces program valued at >=$1B over 5 years for cell-programmed industrial materials, pharmaceuticals, or environmental sensors"
},
{
"kind": "llm_pre_event",
"label": "AI-designed enzyme commercially licensed to Top-20 pharma or specialty chemical co.",
"source": "deep_research_enriched",
"status": "pending",
"weight": 0.4,
"ordinal": -5,
"source_id": null,
"confidence": 0.7,
"expected_date": "2027-11-01",
"research_origin": "deep_research",
"expected_date_range": {
"to": "2028-12-31",
"from": "2026-09-01"
},
"measurement_criterion": "Public press release confirms a generative-AI-designed protein/enzyme licensed for commercial production by a Top-20 pharma or specialty-chemicals firm"
},
{
"kind": "llm_pre_event",
"label": "First cell-programmed industrial product passes $100M annual revenue",
"source": "deep_research_enriched",
"status": "pending",
"weight": 0.4,
"ordinal": -4,
"source_id": null,
"confidence": 0.55,
"source_url": "https://www.inc.com/chloe-aiello/amy-webb-predicts-a-coming-living-intelligence-and-ai-supercycle/91064237",
"expected_date": "2027-12-16",
"research_origin": "deep_research",
"expected_date_range": {
"to": "2028-12-31",
"from": "2026-12-01"
},
"measurement_criterion": "Public 10-K/10-Q from a synbio firm (Ginkgo, Amyris successor, Zymergen-spinout, Cultivarium, etc.) reports a single cell-programmed product at >=$100M trailing-12-month revenue"
},
{
"kind": "quartile_checkpoint",
"label": "Q2 window check-in (50%)",
"status": "pending",
"weight": 0.05,
"ordinal": -3,
"source_id": null,
"expected_date": "2028-01-30",
"observed_date": null
},
{
"kind": "llm_post_event",
"label": "Cell-programmed environmental
... (truncated)